Examination Report |
1 | TM-1 | 17 Jun 2008 |
10 | Hearing Notice | 30 Jul 2014 |
10 | Note Sheet | 30 Jul 2014 |
11 | Hearing Notice | 30 Jul 2014 |
11 | Note Sheet | 30 Jul 2014 |
12 | Order | 31 Dec 2014 |
13 | Certificate | 27 Nov 2015 |
14 | Journal Copy | 28 Nov 2015 |
15 | O-3 Notice | 02 Nov 2017 |
16 | TM-R(RENEWAL OF TRADE MARK) | 11 Jun 2018 |
2 | Additional Representation Sheet | 17 Jun 2008 |
3 | Examination Report | 22 Jan 2009 |
4 | Affidavit | 28 Sep 2010 |
5 | Hearing Notice | 01 Mar 2011 |
6 | Correspondence | 04 Jun 2012 |
7 | Correspondence | 08 Mar 2013 |
8 | Hearing Notice | 24 Sep 2013 |
9 | TM-16 | 07 Oct 2013 |
1 | O3 NOTICE | 5248759 | 19 Oct 2017 | |
2 | RENEWAL NOTICE | 7497802 | 20 Dec 2018 |
Trademark was applied on 17 June 2008 with IP India.
Proprietor of Atrimed red rbc is ATRIMED PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Atrimed red rbc is Registered.
Application number alloted to the trademark is 1699938.
Homi Thomas Mampilly is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE